Sandra Erntoft
Sandra Erntoft publishes mostly in Economics and Econometrics, Epidemiology and Dermatology, on topics such as Nonmelanoma Skin Cancer Studies, Health Systems, Economic Evaluations, Quality of Life and Cutaneous Melanoma Detection and Management.
- World rank
- #3,889,649 of 7,710,434 ranked researchers
- Rank in Denmark
- #27,918 of 43,819
- Works
- 16
- Citations
- 283
- Citations per work
- 17.7
What does Sandra Erntoft research?
Sandra Erntoft's work is mostly in Medicine (54%), Economics, Econometrics and Finance (29%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences958.6%
- Medicine953.7%
- Health Professions14.9%
- Social Sciences529.3%
- Everything else17.2%
- Life Sciences14.9%
- 1Economics and Econometrics29% of their works
- 2Epidemiology24% of their works
- 3Dermatology17% of their works
- 4Oncology12% of their works
- 5Immunology5% of their works
- 6General Health Professions5% of their works
Research topics
- Nonmelanoma Skin Cancer Studies
- Health Systems, Economic Evaluations, Quality of Life
- Cutaneous Melanoma Detection and Management
- Skin Protection and Aging
- Cutaneous lymphoproliferative disorders research
- Psoriasis: Treatment and Pathogenesis
- Healthcare cost, quality, practices
- Nail Diseases and Treatments
Which keywords describe Sandra Erntoft's research?
The keywords of their largest research topics: Skin Cancer, Cost-effectiveness Analysis, Nonmelanoma Skin Cancer, Quality of Life, Skin Cancers, Epidemiology, Dermoscopy and Melanoma.
- TH17 Cells
- Low-Value Care
- Dermatophytes
- Mycosis Fungoides
- UV Radiation
- Melanoma
- Epidemiology
- Quality of Life
- Cost-effectiveness Analysis
- Skin Cancer
- Nonmelanoma Skin Cancer
- Skin Cancers
- Dermoscopy
- Oxidative Stress
- Cutaneous Lymphomas
- Choosing Wisely
- IL-17
- Onychomycosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Skin Cancer92 topics
- Cost-effectiveness Analysis81 topic
- Nonmelanoma Skin Cancer81 topic
- Quality of Life81 topic
- Skin Cancers81 topic
- Epidemiology72 topics
- Dermoscopy51 topic
- Melanoma51 topic
- Oxidative Stress41 topic
- UV Radiation41 topic
- Cutaneous Lymphomas31 topic
- Mycosis Fungoides31 topic
- Choosing Wisely21 topic
- Dermatophytes21 topic
- IL-1721 topic
- Low-Value Care21 topic
- Onychomycosis21 topic
- TH17 Cells21 topic
Where does Sandra Erntoft work?
Sandra Erntoft's main affiliation in the publication record is Leo Pharma (Denmark), Denmark.
How many publications and citations does Sandra Erntoft have?
OpenAlex counts 16 works and 283 citations for Sandra Erntoft, an h-index of 8, ranking #3,889,649 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Sandra Erntoft. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.